Author:
Kalina T, ,Flores-Montero J,van der Velden V H J,Martin-Ayuso M,Böttcher S,Ritgen M,Almeida J,Lhermitte L,Asnafi V,Mendonça A,de Tute R,Cullen M,Sedek L,Vidriales M B,Pérez J J,te Marvelde J G,Mejstrikova E,Hrusak O,Szczepański T,van Dongen J J M,Orfao A
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference63 articles.
1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th edn. International Agency for Research on Cancer: Lyon, 2008; 439 pp.
2. Davis BH, Holden JT, Bene MC, Borowitz MJ, Braylan RC, Cornfield D et al. Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom 2007; 72 (Suppl 1): S5–S13.
3. Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ et al. Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom 2007; 72 (Suppl 1): S14–S22.
4. Stewart CC, Behm FG, Carey JL, Cornbleet J, Duque RE, Hudnall SD et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry 1997; 30: 231–235.
5. Stetler-Stevenson M, Ahmad E, Barnett D, Braylan R, DiGiuseppe J, Marti G et al Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells. Approved guideline. 2nd edn. CLSI document H43-A2 ed. Clinical and Laboratory Standards Institute: Wayne, PA, 2007.